Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings
AUM
$28.4B
1-Year Return
37.22%
This Quarter Return
+4.24%
1 Year Return
+37.22%
3 Year Return
+93.7%
5 Year Return
+199.54%
10 Year Return
+398.51%
AUM
$22.1B
AUM Growth
+$1.49B
(+7.2%)
Cap. Flow
+$1.57B
Cap. Flow
% of AUM
7.11%
Top 10 Holdings %
Top 10 Hldgs %
26.41%
Holding
1,688
New
288
Increased
663
Reduced
425
Closed
302
Top Buys
| 1 |
Invesco MSCI USA ETF
PBUS
|
$259M |
| 2 |
Shopify
SHOP
|
$175M |
| 3 |
Royal Bank of Canada
RY
|
$111M |
| 4 |
Brookfield Asset Management
BAM
|
$110M |
| 5 |
Canadian Natural Resources
CNQ
|
$99.4M |
Top Sells
| 1 |
B
Barrick Mining Corporation
B
|
$124M |
| 2 |
Restaurant Brands International
QSR
|
$102M |
| 3 |
Cenovus Energy
CVE
|
$75.2M |
| 4 |
Procter & Gamble
PG
|
$68.8M |
| 5 |
iShares MSCI India ETF
INDA
|
$68.2M |
Sector Composition
| 1 | Financials | 25.72% |
| 2 | Technology | 20.85% |
| 3 | Energy | 11.79% |
| 4 | Industrials | 11.44% |
| 5 | Materials | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Enanta Pharmaceuticals
ENTA
$189M
| $142K | ﹤0.01% |
24,636
+12,868
| +109% | +$74K |
|
|
NVRO
1352
DELISTED
NEVRO CORP.
NVRO
| $140K | ﹤0.01% |
+37,702
| New | +$140K |
|
1353
SmartRent
SMRT
$275M
| $131K | ﹤0.01% |
74,619
-10,934
| -13% | -$19.1K |
|
1354
Ecopetrol
EC
$18.7B
| $123K | ﹤0.01% |
+15,504
| New | +$123K |
|
1355
Mercer International
MERC
$216M
| $120K | ﹤0.01% |
18,400
-9,423
| -34% | -$61.3K |
|
1356
Telos
TLS
$456M
| $114K | ﹤0.01% |
33,362
-121,483
| -78% | -$415K |
|
1357
DHI Group
DHX
$143M
| $112K | ﹤0.01% |
63,007
+1,348
| +2% | +$2.39K |
|
|
BZUN
1358
Baozun
BZUN
$207M
| $106K | ﹤0.01% |
38,862
-451,909
| -92% | -$1.23M |
|
1359
Regenxbio
RGNX
$490M
| $104K | ﹤0.01% |
13,515
-47,773
| -78% | -$369K |
|
1360
FIGS
FIGS
$1.12B
| $104K | ﹤0.01% |
+16,816
| New | +$104K |
|
1361
OraSure Technologies
OSUR
$236M
| $95.4K | ﹤0.01% |
26,419
-2,312
| -8% | -$8.35K |
|
1362
Crawford & Co Class B
CRD.B
$514M
| $93.8K | ﹤0.01% |
8,067
-2,656
| -25% | -$30.9K |
|
1363
Lineage Cell Therapeutics
LCTX
$279M
| $93.4K | ﹤0.01% |
185,908
-5,528
| -3% | -$2.78K |
|
|
SBDS
1364
Solo Brands, Inc.
SBDS
$18.8M
| $91.2K | ﹤0.01% |
80,018
+7,253
| +10% | +$8.27K |
|
1365
Adverum Biotechnologies
ADVM
$73.9M
| $85.3K | ﹤0.01% |
18,261
+5,057
| +38% | +$23.6K |
|
1366
Gaia
GAIA
$140M
| $75.9K | ﹤0.01% |
16,896
+6,814
| +68% | +$30.6K |
|
1367
Ultrapar
UGP
$4.17B
| $75.6K | ﹤0.01% |
+28,730
| New | +$75.6K |
|
1368
Generation Bio
GBIO
$40.3M
| $67.4K | ﹤0.01% |
6,356
-1,016
| -14% | -$10.8K |
|
1369
Liberty Latin America Class A
LILA
$1.6B
| $66.1K | ﹤0.01% |
+10,393
| New | +$66.1K |
|
1370
UNIFI
UFI
$82.4M
| $65.4K | ﹤0.01% |
+10,471
| New | +$65.4K |
|
|
CRON
1371
Cronos Group
CRON
$957M
| $62.4K | ﹤0.01% |
+31,100
| New | +$62.4K |
|
1372
Biomea Fusion
BMEA
$114M
| $55.7K | ﹤0.01% |
+14,362
| New | +$55.7K |
|
1373
Adicet Bio
ACET
$60M
| $49.2K | ﹤0.01% |
51,175
-129,618
| -72% | -$125K |
|
1374
Eledon Pharmaceuticals
ELDN
$162M
| $46.6K | ﹤0.01% |
+11,303
| New | +$46.6K |
|
|
PFIE
1375
DELISTED
Profire Energy, Inc
PFIE
| $44.9K | ﹤0.01% |
17,668
+2,216
| +14% | +$5.63K |
|